Pharmacodynamic changes of platelet reactivity status in patients with chronic kidney disease after coronary artery stenting
Objectives: This study was to evaluate platelet reactivity over time among patients with chronic kidney disease (CKD) receiving standard dose of clopidogrel after percutaneous coronary intervention (PCI). The effect of CYP2C19 loss-of-function genotypes on platelet reactivity was also determined. Me...
Main Authors: | Zong-Ming Feng, Yong-Qing Lin, Bing-Qing Deng, Xiao-Rong Shu, Xiao Ke, Ru-Qiong Nie |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-05-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332218388206 |
Similar Items
-
Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
by: S. Ramesh, et al.
Published: (2020-11-01) -
Antithrombotic Therapy for Percutaneous Cardiovascular Interventions: From Coronary Artery Disease to Structural Heart Interventions
by: Alessandro Caracciolo, et al.
Published: (2019-11-01) -
Perioperative Outcomes of Patients Undergoing Pulmonary Resection for Lung Cancer after Coronary Stenting
by: Weiming HUANG, et al.
Published: (2020-01-01) -
Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01) -
Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
by: Xiao-Min Jiang, et al.
Published: (2018-01-01)